163 related articles for article (PubMed ID: 35037337)
1. Neurofibromatosis type 2 versus sporadic vestibular schwannoma: The utility of MR diffusion and dynamic contrast-enhanced imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
J Neuroimaging; 2022 May; 32(3):554-560. PubMed ID: 35037337
[TBL] [Abstract][Full Text] [Related]
2. The microenvironment in sporadic and neurofibromatosis type II-related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study.
Lewis D; Donofrio CA; O'Leary C; Li KL; Zhu X; Williams R; Djoukhadar I; Agushi E; Hannan CJ; Stapleton E; Lloyd SK; Freeman SR; Wadeson A; Rutherford SA; Hammerbeck-Ward C; Evans DG; Jackson A; Pathmanaban ON; Roncaroli F; King AT; Coope DJ
J Neurosurg; 2020 May; 134(5):1419-1429. PubMed ID: 32470937
[TBL] [Abstract][Full Text] [Related]
3. Intracranial paragangliomas versus schwannomas: Role of dynamic susceptibility contrast perfusion and diffusion MRI.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
J Neuroimaging; 2022 Sep; 32(5):875-883. PubMed ID: 35562184
[TBL] [Abstract][Full Text] [Related]
4. Advanced MRI to differentiate schwannomas and metastases in the cerebellopontine angle/internal auditory canal.
Ota Y; Liao E; Zhao R; Lobo R; Capizzano AA; Bapuraj JR; Shah G; Baba A; Srinivasan A
J Neuroimaging; 2022 Nov; 32(6):1177-1184. PubMed ID: 35879866
[TBL] [Abstract][Full Text] [Related]
5. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
[TBL] [Abstract][Full Text] [Related]
6. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
[TBL] [Abstract][Full Text] [Related]
7. MR diffusion and dynamic-contrast enhanced imaging to distinguish meningioma, paraganglioma, and schwannoma in the cerebellopontine angle and jugular foramen.
Ota Y; Liao E; Capizzano AA; Yokota H; Baba A; Kurokawa R; Kurokawa M; Moritani T; Yoshii K; Srinivasan A
J Neuroimaging; 2022 May; 32(3):502-510. PubMed ID: 34936708
[TBL] [Abstract][Full Text] [Related]
8. Precise differentiation between jugular foramen paragangliomas and metastases: utility of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging.
Ota Y; Curaudeau G; Liao E; Bapuraj J; Baba A; Shah G; Srinivasan A
Neuroradiology; 2023 Apr; 65(4):805-813. PubMed ID: 36635515
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma.
Malla SR; Bhalla AS; Manchanda S; Kandasamy D; Kumar R; Agarwal S; Shamim SA; Kakkar A
Head Neck; 2021 Sep; 43(9):2611-2622. PubMed ID: 33938085
[TBL] [Abstract][Full Text] [Related]
13. Endoglin (CD105) expression in neurofibromatosis type 2 vestibular schwannoma.
Marioni G; Nicolè L; Cazzador D; Pavone C; D'Avella D; Martini A; Mazzoni A; Zanoletti E
Head Neck; 2019 Oct; 41(10):3612-3617. PubMed ID: 31313389
[TBL] [Abstract][Full Text] [Related]
14. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
[TBL] [Abstract][Full Text] [Related]
15. DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml.
Sun H; Du F; Liu Y; Li Q; Liu X; Wang T
Front Oncol; 2022; 12():925186. PubMed ID: 36578948
[TBL] [Abstract][Full Text] [Related]
16. Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.
Li KL; Djoukhadar I; Zhu X; Zhao S; Lloyd S; McCabe M; McBain C; Evans DG; Jackson A
Neuro Oncol; 2016 Feb; 18(2):275-82. PubMed ID: 26311690
[TBL] [Abstract][Full Text] [Related]
17. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
[TBL] [Abstract][Full Text] [Related]
18. Facial Nerve Outcomes After Vestibular Schwannoma Microsurgical Resection in Neurofibromatosis Type 2.
Sobieski C; Killeen DE; Barnett SL; Mickey BE; Hunter JB; Isaacson B; Kutz JW
Otolaryngol Head Neck Surg; 2021 Apr; 164(4):850-858. PubMed ID: 32957864
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.
Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J
Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
